Alemtuzumab and Medroxyprogesterone Injection (Subcutaneous)
Determining the interaction of Alemtuzumab and Medroxyprogesterone Injection (Subcutaneous) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: n.a.
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: Medroxyprogesterone, MedroxyPROGESTERone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab-Medroxyprogesterone Injection ER
- Alemtuzumab-Medroxyprogesterone Intramuscular
- Alemtuzumab-Medroxyprogesterone Tablets
- Alemtuzumab-Medworx Patch
- Alemtuzumab-Mefenamic acid
- Alemtuzumab-Mefloquine
- Medroxyprogesterone Injection (Subcutaneous)-Alemtuzumab (Campath)
- Medroxyprogesterone Injection (Subcutaneous)-Alemtuzumab (Lemtrada)
- Medroxyprogesterone Injection (Subcutaneous)-Alemtuzumab Intravenous
- Medroxyprogesterone Injection (Subcutaneous)-Alenaze-D
- Medroxyprogesterone Injection (Subcutaneous)-Alendronate
- Medroxyprogesterone Injection (Subcutaneous)-Alendronate and cholecalciferol